06/02/2025
7:06 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025
3:03 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2025
10:59 AM | Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
9:47 AM | Ascendis Pharma A/S (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G | |
05/12/2025
11:13 AM | Ascendis Pharma A/S (Subject)
Shu Aimee (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025
6:18 AM | Ascendis Pharma A/S (Subject)
Shu Aimee (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025
3:14 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025
3:15 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2025
3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025
3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2025
3:17 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for ASND and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. |
03/12/2025
3:48 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025
4:03 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
3:51 PM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
1:31 PM | Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:38 PM | Ascendis Pharma A/S (Subject)
Hartvig Camilla Harder (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:27 PM | Ascendis Pharma A/S (Subject)
Fairey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:32 PM | Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:15 PM | Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:22 PM | Ascendis Pharma A/S (Subject)
IMANI SIHAM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:50 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:55 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:00 PM | Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:04 PM | Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:09 PM | Ascendis Pharma A/S (Subject)
Cha Albert (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
7:12 PM | Ascendis Pharma A/S (Subject)
HOLTUG LARS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:40 PM | Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:45 PM | Ascendis Pharma A/S (Subject)
SPROGOE KENNETT (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:02 PM | Ascendis Pharma A/S (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/21/2025
5:11 AM | Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
4:06 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:56 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
10:54 AM | Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
3:15 PM | Ascendis Pharma A/S (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/12/2025
2:24 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2025
8:15 AM | Ascendis Pharma A/S (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SCHEDULE 13G/A | |
01/15/2025
3:39 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025
5:03 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025
5:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
3:04 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024
5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
3..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad) I just put together an urgent new presentation that you need to see right away.
In short: I believe we are mere days away from a critical announcement from a key tech leader…
One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.  Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
12/10/2024
4:02 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
4:07 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
4:16 PM | Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:44 PM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
3:35 PM | Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:46 PM | Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
1:57 PM | Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024
8:31 AM | Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:02 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024
8:51 AM | Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
11/08/2024
9:34 AM | Ascendis Pharma A/S (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/04/2024
6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
7:35 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024
3:59 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
4:20 PM | Ascendis Pharma A/S (Filer)
| Form 424B5 | |
09/18/2024
3:01 PM | Ascendis Pharma A/S (Filer)
| Form F-3ASR | |
09/16/2024
6:28 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
6:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:14 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024
6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
